Abstract
Introduction

26
Percutaneous absorption/permeation of a drug molecule (e.g., lidocaine) through skin depends 27 on the contact between the formulation and skin properties through which the drug molecules 
261
The results show that the lidocaine solution spreading radii for 3.9 N and 7.9 N forces of 1100 262 µm long (longer MNs) MN is distinctly different as compared to the lidocaine hydrogel spreading 263 radii (Figures 3a and 3c) . However, no significant difference in droplet spreading radii was 264 observed when comparing 3.9 and 7.9 N force of 600 µm long MN (shorter MNs) for lidocaine 265 solution (Figure 3a) . In further scrutinising spreading patterns the lidocaine solution showed 266 rapid spreading, faster decrease in droplet height and rapid decrease in dynamic contact angle 267 as compared with lidocaine hydrogel when the same forces, namely, 3.9 N force was applied on 268 the skin (Figure 3d ).
270
The artificial membrane (Strat-M), which is normally implemented in drug based in vitro passive 
297
The relative humidity and temperature of the surrounding vicinity for droplet spreadability was 
320
These are discussed below.
322
The lidocaine hydrogel spreading on 3.9 N and 7.9 N force treated skin with 1100μm and 600 C 3.9 N, 600um C 3.9 N, 1100um C 7.9 N, 600um C 7.9 N, 1100um S 3.9 N, 600UM S 3.9 N, 1100um S 7.9 N, 1100um s 7.9 N, 600um S 15.7 N, 600um S 15.7 N, 1100um t/t* C 3.9 N, 600um C 3.9 N, 1100um C 7.9 N, 1100um S 3.9 N, 1100um S 7.9 N, 1100um S 15.7 N, 1100um S 3.9 N, 600um S 7.9 N, 600Um S 15.7 N, 600um 
